Condition
Hormone Replacement
Total Trials
3
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
P 1 (1)
P 4 (1)
Trial Status
Completed3
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT01487057Completed
Lipid Metabolic Status in Thyroid Carcinoma
NCT00755963Phase 4CompletedPrimary
Effects of Hormone Replacement Therapy on the Serotonergic System and Mood in Postmenopausal Women
NCT01088841Phase 1Completed
Sweet Taste Receptors and the Secretion of Glucagon-like Peptide-1 and Peptide YY
Showing all 3 trials